Conference
7024 Phase Ib dose-finding trial of intravenous (i.v.) panobinostat (PAN) with docetaxel (DOC) and prednisone (PRED) in patients (pts) with castration resistant prostate cancer (CRPC)
Authors
Vaishampayan U; Rathkopf D; Chi KN; Hotte S; Vogelzang N; Alumkal J; Agrawal M; Picus J; Fandi A; Scher HI
Volume
7
Pagination
pp. 413-414
Publisher
Elsevier
Publication Date
September 1, 2009
DOI
10.1016/s1359-6349(09)71402-8
Conference proceedings
European Journal of Cancer Supplements
Issue
2
ISSN
1359-6349